Just sent out my most recent Substack writeup to the free subscribers.

The company I profiled this week was $APPH aka @AppHarvest

You can read it here: jonahlupton.substack.com/p/apph-appharv… Image
$APPH is building indoor vertical farms which I believe is the future of farming and our food supply.

There are dozens of benefits to indoor farming including water efficiency and no pesticides but the number that blew my mind was 30x crop yield per acre versus outdoor farming. Image
$APPH is operating their first facility in Morehead, KY which is 2.8 million sq feet.

They're already started building their next two facilities in KY and once those are done they'll start building in NY

These facilities will grow tomatoes, peppers, cucumbers and leafy greens. Image
The company has stated they want 12 facilities up and running by 2025.

I can easily envision a future where $APPH has 50+ facilities all around the country which would cut down on transportation costs and ensure our fruits and veggies are even fresher. Image
$APPH stock has pulled back nearly 50% over the past two weeks which provides a very attractive entry price in my opinion.

$APPH is one of the only publicly traded certified-B corps which means they are committed to doing good for people & the planet, not just making profits. Image
I believe that $APPH will quickly become a favorite for ESG investors as they learn more about this company and want to support their mission.

Right now the US is importing close to 50% of our fruits and vegetables from other countries which is unacceptable. Image
We need to be growing our foods here, pesticide and GMO free, close to the customer and at affordable costs.

$APPH is basically building high-tech greenhouses, packed with sensors and robotics to ensure maximum productivity and efficiency. Image
$APPH even collects all the rainwater in their 10-acre retention ponds then filters it because circulating it through the closed-loop irrigation system so no water is ever wasted.

I'm also interviewing the Founder & CEO next Thursday. Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Jonah Lupton

Jonah Lupton Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @JonahLupton

5 Mar
Here is my recent interview with Thomas Sandgaard, Founder & CEO of @ZynexMedical aka $ZYXI

$ZYXI devices are used for pain management and recovery from injury/surgery -- hopefully instead of opioids

Watch here:
$ZYXI is the leader in electro-stimulation devices and they are 10x better than the crappy ones you buy on Amazon

$ZYXI devices have to be prescribed by a medical professional and given that my entire body hurts most days I'll be visiting my doctor very soon to get one.
$ZYXI is $80+ million in revenues in 2020 which was 76% YoY growth

$ZYXI also has 78% gross margins and is already profitable.

Thomas thinks $ZYXI can do $150M in 2021 and $300M in 2022

$ZYXI doubled the size of their sales force in 2020 and now have 500+ sales people.
Read 5 tweets
5 Mar
Several people have asked me why I'm willing to pay 65x sales for $DMTK - it's a good question so here's my answer:

When you find a company like $DMTK that has the potential to grow revenues at 200% annually for the next 4+ years you don't sit back and wait for it to look cheap.
By the time $DMTK looks cheap it might be a $30+ billion company.

You have to adjust your mindset in you want to invest in these hypergrowth companies that have a smaller revenue base now but massive upside thanks to years of insane growth in the future.
Here are my revenue projections for $DMTK based on their current PLA product, Luminate, PLA+ and several other pipeline products:

2021 = $21M+
2022 = $70M+
2023 = $210M+
2024 = $550M+
2025 = $1,000M+

If $DMTK can get to $1+ billion in 2025 this will be a $25+ billion company
Read 7 tweets
5 Mar
Seems like two bad weeks in the markets brings out the worst in some people. It’s too bad b/c I love twitter but some people make it intolerable on certain days. It’s sad that these people have nothing better to do than create fake profiles for the purpose of harassing others.
I have always done my best to provide/create valuable content and help others become better investors.

I’m far from perfect. I don’t have a crystal ball. I make plenty of mistakes like everyone else.
All I can do is try my hardest to find great companies that can deliver strong returns for investors.

I have no idea what these companies will do in the short term. These are companies I want to own for many years.
Read 18 tweets
4 Mar
Solid numbers from $DMTK

Assay revenues up 214% YoY

$DMTK has a bright future. This is going to be a hypergrowth company for the next 3-4 years with current PLA product + Luminate + other genomics skin testing products in the pipeline.

$DMTK up 8% AH

businesswire.com/news/home/2021…
CEO just said that 85 million people have coverage for $DMTK smart patches through their insurance provider
CEO just said that Luminate is on track to be launched in 2021 Q4
Read 4 tweets
3 Mar
Just wrapped up a great interview with Thomas Sandgaard, Founder & CEO of $ZYXI -- @ZynexMedical

It's insane how undervalued $ZYXI is right now. The company has already given guidance for 2021 revenues around $150M and Thomas thinks they might be able to do $300M in 2022.
With a market cap under $500M this stock is trading at 3x 2021 sales and less than 2x 2022 sales.

Did I mention they have 78% gross margins and are already profitable.

They also have two new products coming to market later this year:
1) blood flow/loss monitor
2) sepsis monitor
It's worth mentioning that Thomas owns 46% of the company so he has more skin in the game than the average Founder or CEO -- I love this.

This interview will be sent to all Substack paid subscribers later today and then my free subscribers will get it later this week.
Read 4 tweets
3 Mar
One of the things we have to do as fund managers at Social Capital is submit a one-page writeup for any holdings that are 5% or greater.

I think this is a valuable exercise for all investors and I encourage others to do this for their personal portfolios.
I already submitted my writeups on $DMTK and $UPST

My conviction for both of these stocks is just as strong today as it was the first day I started buying them. In many ways it's even stronger now.

$UPST is growing at 60-70% with 84% gross margins 😍
If you're looking for a template, the sections in my writeup were:

- Stock Price / Market Cap / Enterprise Value

- Overview / Growth Strategy

- Valuation / Financials

- Catalysts / Upside

- Risks / Downside

- Position Sizing
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!